Lentigen focuses on harnessing the power of lentiviral gene delivery and expression technology for a wide variety of applications in biotechnology and medicine. We are leading experts for design, construction and production of lentiviral vectors. Lentigen has the expertise to support you in successfully translating your gene therapeutic strategy into the clinic. GMP Manufacturing, Materials Management, Validation, Quality Control, Quality Assurance and a focused Project Management ensure high quality of your customized lentiviral product and conformity with regulatory requirements. Since 2014, Lentigen is a wholly owned subsidy of Miltenyi Biotec, a global provider of innovative solutions in biomedical research and cell and gene therapy.